Updated Jun. 14, 2013 at 6:50 a.m.

Premium Lock Antibiotics firm Cempra plans stock sale; proceeds to fund clinical trials

Published: 2013-06-14 06:40:00
Updated: 2013-06-14 06:50:32

Print this blog post
Cempra Cempra

Coming off of two major wins in the last month, antibiotics developer Cempra announces plans for a stock sale. WRALtechWire Learn more about the plans....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners


Vivek Wadhwa
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy